Search Results for 'Niraparib'

Case Discussion: Second

• celsa-spraggs
• 0 Slides

Opinion. 55 year-old woman with . recurrent . ova...

ESP1/SARC025 Global Collaboration: A Phase I Study of a Combination of the PARP inhibitor,

• marina-yarberry
• 0 Slides

Niraparib. and . Temozolomide. in Patients with...

The Nurse View: Clinical Considerations in the Management of

• natalia-silvester
• 0 Slides

BRCA. -Mutated Advanced Ovarian Cancer. Moderator...

• littleccas
• 21 Slides

actual. . video-recorded proceedings from the . l...

• medshair
• 44 Slides

Five-year . survival. 15%. 30%. 40%. ?50%?. First ...

Clinical Trials Oct . 6, Lyon France

• wayne461
• 14 Slides

Birthe Lemley. Executive. Board . Member. of ENG...

Learning Objectives Summarize the latest evidence on poly ADP ribose polymerase (PARP) inhibitors i

• zen
• 21 Slides

knowledge. ). Incorporate evidence-based research ...